Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. [electronic resource]
Producer: 20050111Description: 6119-25 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Cell Line, Tumor
- Cholecystitis -- diagnosis
- Cyclin-Dependent Kinase Inhibitor p16 -- biosynthesis
- DNA Methylation
- DNA Restriction Enzymes -- pharmacology
- Female
- Gallbladder Neoplasms -- pathology
- Gene Silencing
- Humans
- Male
- Middle Aged
- Polymerase Chain Reaction
- Promoter Regions, Genetic
- Statistics as Topic
- Sulfites -- pharmacology
- Treatment Outcome
- Tumor Suppressor Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.